IP Library Patent Application 12032346
Patent Application
App. No. 12/032,346

SYSTEMS AND METHODS FOR PREPARING AUTOLOGOUS FIBRIN GLUE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/032,346
Abstract

A method of regenerating tissue in a living organism. The method includes the act of contacting an affected area of the living organism with a solid-fibrin web, the solid-fibrin web comprising platelets that release growth factors about one minute after contact to regenerate the tissue in the living organism.

Claims (37)

1 . A method of regenerating tissue in a living organism, the method comprising:

contacting an affected area of the living organism with a solid-fibrin web, the solid-fibrin web comprising platelets that release growth factors about one minute after contact to regenerate the tissue in the living organism.

2 . The method of claim 1 , wherein the solid-fibrin web comprises platelets that release growth factors about thirty minutes after contact.

3 . The method of claim 1 , wherein the solid-fibrin web comprises platelets that release growth factors about seven days after contact.

4 . The method of claim 1 , wherein the platelets provide for sustained release of growth factors over a period of time of from about one minute to about seven days.

5 . The method of claim 1 , wherein substantially all of the platelets are substantially intact prior to and at contact.

6 . The method of claim 1 , further comprising separating plasma from blood, contacting the plasma with a coagulation activator, and coagulating and centrifuging the plasma to form the solid-fibrin web.

7 . The method of claim 6 , whereby coagulating and centrifuging the plasma to form the solid-fibrin web are performed concurrently.

8 . The method of claim 6 , wherein the coagulation activator is not heterologous thrombin or batroxobin.

9 . The method of claim 6 , wherein the coagulation activator is not heterologous collagen or ADP.

10 . The method of claim 6 , wherein the coagulation activator comprises a calcium-coagulation activator.

11 . The method of claim 10 , wherein the calcium-coagulation activator is selected from calcium chloride, calcium fluoride, calcium carbonate and combinations thereof.

12 . A method of regenerating tissue in a living organism, the method comprising:

contacting an affected area of the living organism with a solid-fibrin web, the solid-fibrin web comprising platelets substantially all of which are substantially intact prior to and at contact, the platelets releasing growth factors after contact to regenerate the tissue in the living organism.

13 . The method of claim 12 , wherein the solid-fibrin web comprises platelets that release growth factors about one minute after contact.

14 . The method of claim 12 , wherein the solid-fibrin web comprises platelets that release growth factors about thirty minutes after contact.

15 . The method of claim 12 , wherein the platelets provide for sustained release of growth factors over a period of time of from about one minute to about seven days.

16 . The method of claim 12 , further comprising separating plasma from blood, contacting the plasma with a coagulation activator, and coagulating and centrifuging the plasma to form the solid-fibrin web.

17 . The method of claim 16 , whereby coagulating and centrifuging the plasma to form the solid-fibrin web are performed concurrently.

18 . The method of claim 16 , wherein the coagulation activator is not heterologous thrombin or batroxobin.

19 . The method of claim 16 , wherein the coagulation activator is not heterologous collagen or ADP.

20 . The method of claim 16 , wherein the coagulation activator comprises a calcium-coagulation activator.

21 . The method of claim 20 , wherein the calcium-coagulation activator is selected from calcium chloride, calcium fluoride, calcium carbonate and combinations thereof.

22 . A method of regenerating tissue in a living organism, the method comprising:

preparing a solid-fibrin web without the use of heterologous thrombin or baxtroxobin; and

contacting an affected area of the living organism with the solid-fibrin web to regenerate the tissue in the living organism.

23 . The method of claim 22 , wherein the solid-fibrin web comprises platelets that release growth factors about one minute after contact to regenerate the tissue in the living organism.

24 . The method of claim 23 , wherein the platelets are substantially intact prior to and at contact.

25 . The method of claim 22 , wherein the platelets are substantially intact prior to and at contact.

26 . The method of claim 22 , wherein the solid-fibrin web has platelets that release growth factors about thirty minutes after contact.

27 . The method of claim 22 , wherein the solid-fibrin web has platelets that release growth factors about seven days after contact.

28 . The method of claim 22 , wherein the platelets provide for sustained release of growth factors over a period of time of from about one minute to about seven days.

29 . The method of claim 22 , further comprising separating plasma from blood, contacting the plasma with a coagulation activator, and coagulating and centrifuging the plasma to form the solid-fibrin web.

30 . The method of claim 29 , whereby, coagulating and centrifuging the plasma to form the solid-fibrin web are performed concurrently.

31 . The method of claim 29 , wherein the coagulation activator comprises a calcium-coagulation activator.

32 . The method of claim 31 , wherein the calcium-coagulation activator is selected from calcium chloride, calcium fluoride, calcium carbonate and combinations thereof.

33 . The method of claim 22 , wherein heterologous the solid-fibrin web is prepared without the use of collagen or ADP.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 6, 2021
From: SIGULER GUFF PVT DEBT HOLDINGS, LLC
To: PULSE VETERINARY TECHNOLOGIES, LLC
Reel/Frame 057716/0286 →
SECURITY INTEREST Recorded Sep 6, 2019
From: PULSE VETERINARY TECHNOLOGIES, LLC
To: SIGULER GUFF PVT DEBT HOLDINGS, LLC
Reel/Frame 050291/0891 →
LICENSE Recorded Nov 10, 2010
From: CASCADE MEDICAL ENTERPRISES, LLC
To: PULSE VETERINARY TECHNOLOGIES, LLC
Reel/Frame 025344/0956 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2008
From: BERETTA, ROBERTO; GRIPPI, NICHOLAS A.
To: CASCADE MEDICAL ENTERPRISES, LLC
Reel/Frame 020902/0211 →